GlassScriptPhysician profile
Kent Lyon
NPI 1063476364
$4,389.40
in general payments reported to CMS, 2019-2025
42 companies · $776 in 2025
The $776 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $717 · 2021: $1,385 · 2022: $811 · 2024: $346 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $763.06 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $572.04 | 2019-2022 | |
| Dexcom, INC. | $537.30 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $407.65 | 2019-2025 | Saphnelo |
| Sanofi-Aventis U.S. LLC | $241.94 | 2019-2022 | |
| Radius Health, INC. | $197.02 | 2025 | Tymlos |
| Janssen Biotech, INC. | $177.38 | 2024-2025 | Tremfya |
| Xeris Pharmaceuticals, INC. | $137.09 | 2021-2025 | Gvoke Hypopen |
| Insulet Corporation | $130.51 | 2019-2025 | Omnipod |
| Beta Bionics, INC. | $129.08 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amgen INC. | $109.11 | 2019-2022 | |
| Pfizer INC. | $105.34 | 2019-2022 | |
| Abbott Laboratories | $81.55 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $75.63 | 2025 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $63.34 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.